================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
July 28, 2005
______________________
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-32431 90-0199783
-------- --------- ----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
100 Potrero Avenue
San Francisco, CA 94103-4813
(Address of principal executive offices, including zip code)
(415) 558-0200
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
1
Section 2 - Financial Information
ITEM 2.02 Results of Operations and Financial Condition.
The following information is intended to be furnished under Item 2.02 of
Form 8-K, "Results of Operations and Financial Condition." This information
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such a filing.
On July 28, 2005, Dolby Laboratories, Inc. issued a press release
announcing its financial results for its third fiscal quarter ended July 1,
2005. The full text of the press release is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
Section 9 - Financial Statements and Exhibits
ITEM 9.01 Financial Statements and Exhibits.
(c) Exhibits
The following exhibit is furnished herewith:
Exhibit No. Description
----------- -----------
99.1 Press Release of Dolby Laboratories, Inc. dated July 28, 2005.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC.
By: /s/ Janet L. Daly
--------------------------------------------
Janet L. Daly
Vice President, Chief Financial Officer
(Principal Accounting and Financial Officer)
Date: July 28, 2005
3
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release of Dolby Laboratories, Inc. dated July 28, 2005.
4